Follow
Vilashini Rajaratnam
Vilashini Rajaratnam
PhD Candidate
Verified email at uwm.edu
Title
Cited by
Cited by
Year
Glioblastoma: Pathogenesis and current status of chemotherapy and other novel treatments
V Rajaratnam, MM Islam, M Yang, R Slaby, HM Ramirez, SP Mirza
Cancers 12 (4), 937, 2020
1212020
Proteins inform survival-based differences in patients with glioblastoma
LC Stetson, QT Ostrom, D Schlatzer, P Liao, K Devine, K Waite, ...
Neuro-Oncology Advances 2 (1), vdaa039, 2020
62020
The development and validation of sensitive LC-MS/MS method for quantitative bioanalysis of carmofur in mouse plasma and its application to pharmacokinetic study
MM Islam, EF Kub, V Rajaratnam, SP Mirza
Journal of Chromatography B 1212, 123516, 2022
22022
Development and validation of an LC–MS/MS method for the determination of ARN14988, an acid ceramidase inhibitor, and its application to a pharmacokinetic study in a mouse model
V Rajaratnam, MM Islam, EF Kub, S Rajaratnam, KB Kim, MT Rahman, ...
Biomedical Chromatography 38 (1), e5754, 2024
2024
Neuro-Oncology Advances
SF Svensson, S Halldórsson, A Latysheva, E Fuster-Garcia, T Hjørnevik, ...
2023
Physicochemical Properties, Pharmacokinetics and Biodistribution of ARM14988, an Acid Ceramidase Inhibitor, and Its Potential as Chemotherapeutic Agent for Glioblastoma
V Rajaratnam
2022
An efficient debromination technique using PMHS with a number of ligands containing different functional groups
MY Mian, P Mondal, D Sharmin, KP Pandey, F Rashid, S Rezvanian, ...
Arkivoc, 171-188, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–7